UBS Group’s Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CRU.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-774
Closed 11583
2022
Q1
$0 Buy
+774
New +$366 ﹤0.01% 11437
2021
Q4
Sell
-3,869
Closed -$3K 11176
2021
Q3
$3K Buy
+3,869
New +$3.93K ﹤0.01% 8898

Other funds holding CRU.WS

UBS Group's CRU.WS Position: Q2 2022 in Review

UBS Group sold out of Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CRU.WS) in Q2 2022, closing a stake of 774 shares.

UBS Group first reported a position in CRU.WS in Q3 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 46 funds tracked by Wall St. Rank hold CRU.WS as of Q2 2022.

  • UBS Group reported no remaining Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • UBS Group sold 774 Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q2 2022.
  • UBS Group first reported a position in Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q3 2021 and held it in 2 quarters.
  • UBS Group's Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $3K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q2 2022.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.